1. 1105TiPPembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial. (18th September 2017) Authors: Machiels, J-P.; Licitra, L.; Rischin, D.; Waldron, J.; Burtness, B.; Grégoire, V.; Shekar, T.; Brown, H.M.; Cheng, J.; Siu, L.L. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM). (23rd June 2022) Authors: Wilck, M.; Cornely, O.; Ljungman, P.; Cordonnier, C.; Diego Velez, J.; Dagan, R.; Richmond, P.; Chen, Q.; Daus, C.; Geddie, K.; Sterling, T.; Shekar, T.; Musey, L.; Buchwald, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗